Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > SentiMag® Now Available in Australia and New Zealand

Abstract:
Endomagnetics is pleased to announce it has reached an agreement with Aurora BioScience as its exclusive distributor for Australia and New Zealand. This appointment significantly extends the availability of the company's SentiMag® and Sienna+® tracer system. Breast cancer patients in the region will now have access to new technology that optimally locates lymph nodes as part of the cancer staging procedure in Sentinel Lymph Node Biopsy (SLNB).

SentiMag® Now Available in Australia and New Zealand

Cambridge, UK | Posted on July 21st, 2014

Current standard-of-care for SLNB requires a radioactive isotope injection, which has limited availability in Australia and New Zealand. The SentiMag system increases the availability of the standard-of-care and also improves workflow, putting the surgeon in control of tracer injection. The system has been used in 10 clinical studies and trials with over 1,500 patients across 12 European countries since 2012. The first two trials have published recently, and demonstrated clinical equivalence to the standard-of-care.

Aurora Bioscience is exclusively responsible for the sales, marketing and distribution of the SentiMag® system in the Australian and New Zealand markets. Aurora is a leading specialist distributor of high technology medical devices across fields including oncology, blood technology, respiratory medicine and neurology. It provides a service to metropolitan and regional areas across Australia and New Zealand and around the Pacific Islands.

Mathew Stephens, Director of Sales and Business Development at Endomagnetics said: "We are delighted to be working with the team at Aurora as this appointment significantly strengthens our distribution in this key geographical market. The interest from Australian and New Zealand surgeons has been huge and we are looking forward to developments in the coming months."

For Aurora BioScience, Darren Banks, Managing Director said: "The Endomagnetics technology is a perfect fit with our advanced, innovative range of medical devices, and the technology will significantly improve patient experience by extending availability of the SLNB technique".

####

About Endomagnetics
Endomagnetics Ltd was founded to solve cancer staging and healthcare challenges through the application of advanced magnetic sensing technology and nanotechnology. Endomagnetics is developing a portfolio of medical device products based on a patented ability to detect magnetic materials in the human body with exceptional sensitivity. The technology was originally developed at University College London and the University of Houston.

The company’s first product, the SentiMag®, is an ultrasensitive hand-held probe for tracking injected Sienna+® nanoscale magnetic materials in the human body. Cambridge, UK-based Endomagnetics is in the process of delivering its technology to global markets.

About Aurora BioScience

Located in Sydney Australia, Aurora BioScience Pty Ltd is committed to providing advanced, high quality medical devices and healthcare products to assist medical professionals within Australia, New Zealand and the Pacific Islands healthcare markets, to contribute to the enhancement of patient’s quality of life. Areas of interest include cancer therapies, neurology, pulmonology, and haematology and blood products.

For more information, please visit www.aurorabioscience.com.au

For more information, please click here

Contacts:
Editorial contact:
Terry Nicklin
KeynotePR Ltd
Tel: +44 (0)7923 540695


Company contact:
Dr Eric Mayes, CEO
Endomagnetics Ltd
Tel: +44 (0)1223 652540

Copyright © Endomagnetics

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Nanoscale worms provide new route to nano-necklace structures March 29th, 2015

Solving molybdenum disulfide's 'thin' problem: Research team increases material's light emission by twelve times March 29th, 2015

A first glimpse inside a macroscopic quantum state March 28th, 2015

DFG to Establish One Clinical Research Unit and Five Research Units: New Projects to Investigate Complications in Pregnancy, Particle Physics, Nanoparticles, Implants and Transport Planning / Approximately 13 Million Euros in Funding for an Initial Three-Year Period March 28th, 2015

Imaging

FEI Technology Award of the German Neuroscience Society Goes to Benjamin Judkewitz of the University of Berlin: Bi-annual award honors excellence in brain research during the German Neuroscience Society’s Annual Meeting, held 18-21 March 2015 March 26th, 2015

Square ice filling for a graphene sandwich March 26th, 2015

Renishaw reports on the use of Raman spectroscopy at CNRS Orléans to study materials under extreme conditions March 25th, 2015

Nanorobotic agents open the blood-brain barrier, offering hope for new brain treatments March 25th, 2015

Nanomedicine

Novel nanoparticle therapy promotes wound healing March 27th, 2015

Graphene reduces wear of alumina ceramic March 26th, 2015

Application of Graphene Oxide in Body Implants in Iran March 26th, 2015

Nanorobotic agents open the blood-brain barrier, offering hope for new brain treatments March 25th, 2015

Announcements

Nanoscale worms provide new route to nano-necklace structures March 29th, 2015

Solving molybdenum disulfide's 'thin' problem: Research team increases material's light emission by twelve times March 29th, 2015

A first glimpse inside a macroscopic quantum state March 28th, 2015

DFG to Establish One Clinical Research Unit and Five Research Units: New Projects to Investigate Complications in Pregnancy, Particle Physics, Nanoparticles, Implants and Transport Planning / Approximately 13 Million Euros in Funding for an Initial Three-Year Period March 28th, 2015

Alliances/Partnerships/Distributorships

NXP and GLOBALFOUNDRIES Announce Production of 40nm Embedded Non-Volatile Memory Technology: Co-developed technology to leverage GLOBALFOUNDRIES 40nm process technology platform March 24th, 2015

Young NTU Singapore spin-off clinches S$4.3 million joint venture with Chinese commercial giant March 23rd, 2015

Halas, Nordlander awarded Optical Society's R.W. Wood Prize: Rice University researchers recognized for pioneering nanophotonics March 21st, 2015

EU Funded PCATDES Project has completed its half-period with success March 19th, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2015 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE